Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.
Pharmaceutical Technology on MSN6d
USPTO allows patents for Remedy’s large hemispheric infarction drugThe US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara, aimed at treating ...
A new meta-analysis examines the effects of dual antiplatelet therapy after thrombolysis in minor stroke patients. Findings ...
The National Institutes of Health Stroke Scale (NIHSS) is accepted as the definitive clinical examination to assess stroke severity. This project examined barriers to implementation and NIHSS use ...
Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric ...
Acute ischemic stroke, which occurs due to a blockage in cerebral blood flow, requires prompt intervention with thrombolytic ...
A project was developed to determine the barriers to NIHSS use by the nursing staff, to develop and implement a plan to improve the completion rate, and to evaluate progress as interventions were ...
Methods 15 patients (mean age 60.6 years, mean National Institutes of Health Stroke Scale (NIHSS) score 2.25) and 10 age matched control subjects (mean age 63.3 years) participated in the study. We ...
Methods Patients were prospectively enrolled at two comprehensive stroke centers during stroke alert evaluation within 24 hours of onset with National Institutes of Health Stroke Scale (NIHSS) score ...
admission NIHSS and ASPECTS, pre-stroke mRs≥1, intravenous rt-PA, onset to recanalization time, and recanalization grades (mTICI 2b vs 2 c/3). We investigated the heterogeneity in the association ...
Strokes are treatable, so it is important to be able to recognize a stroke so that you can get the right emergency treatment as quickly as possible. If you see or experience any of the following ...
HotCopper on MSN1h
Clinuvel stroke drug shows 'positive' results – but some adverse effects left unclearClinuvel (ASX:CUV) shares have jumped on Tuesday morning on higher than average volumes as the health care company reported a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback